Scott Wiesen
Gastroenterology · Naples, FLNPI 1831130814
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,452 of the $2,884 with a category attached, or 85.0%. It is spread thinly across 19 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,015 and has fallen 97.7% since, to $23 in 2024. That places this record below the midpoint for gastroenterology clinicians in FL, where the typical reported total is $3,025.
Across 133 payments — averaging $21.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$620
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$381
- Johnson & Johnson$364
- Braintree Laboratories, Inc.$337
- Redhill Biopharma Inc.$239
- Takeda Pharmaceuticals U.S.A., Inc.$188
- plus $755 from 13 others
What the payments were for
- Food & beverage$2,45285%
- Education$1274%
- Gifts$30511%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 32 | $620 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 20 | $381 |
| Johnson & Johnson | 17 | $364 |
| Braintree Laboratories, Inc. | 13 | $337 |
| Redhill Biopharma Inc. | 17 | $239 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $188 |
| E.r. Squibb & Sons, L.L.C. | 2 | $140 |
| Janssen Scientific Affairs, LLC | 1 | $125 |
| Cook Medical LLC | 1 | $123 |
| Mauna Kea Technologies, Inc. | 3 | $115 |
| Intercept Pharmaceuticals, Inc. | 3 | $50 |
| Merck | 2 | $39 |
| Bristol Myers Squibb | 2 | $30 |
| Gilead | 2 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| Pfizer | 1 | $24 |
| Ardelyx, Inc. | 1 | $22 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Shire North American Group Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,884 in reported general payments places this provider in the 45th percentile of 1,388 gastroenterology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 13 | $177 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Naples
- William ProvanceNaples$74K
- Samuel GidayOrlando$2M
- Lukasz KwapiszMiami$1.2M
- Jennifer Seminerio-DiehlOrlando$1.1M
- Udayakumar NavaneethanSaint Petersburg$1.1M
- Ronen AraiCoral Springs$1.1M
- Charles SninskyGainesville$983K
- Peter DraganovGainesville$832K
- Arin NewmanMiami Beach$716K
- Joanna LopezMiami$670K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.